 |
|
|
| |
Are risk factors still relevant for HCV treatment with directly-acting agents against HCV in HIV-HCV-coinfection?
Results from the German hepatitis C cohort (GECCO)
|
| |
| |
Reported by Jules Levin
AASLD 2016 Nov 11-15 Boston, MA
Stefan Mauss1 , Patrick Ingiliz2, Thomas Lutz3, Knud Schewe4, Juergen Rockstroh5, Florian Berger1, Heiner Busch6, Julian Schulze zur Wiesch7, Axel Baumgarten2, Guenther Schmutz1, Stefan Christensen6
1 Center for HIV and Hepatogastroenterology, Duesseldorf, 2 Center for Infectiology Berlin, Berlin, 3 Infektiologikum, Frankfurt, 4 Infektionsmedizinisches Centrum Hamburg, Hamburg, 5 Medical Department 1, University Hospital Bonn,
Bonn, 6 CIM Infectious diseases, Muenster, 7 I.Department of Medicine, University Medical Center Hamburg-Eppendorf, Germany
|
| |
|
|
|
|
|
